Our science & medical news
RSS feedThe value of myostatin measurement in the follow-up of inflammatory myopathies
Measuring the activity of an inflammatory pathology such as inclusion myositis or autoimmune necrotizing myopathy is not easy. Researchers at the Institute of Myology in Paris have investigated the hypothesis that the determination of myostatin, a muscle growth inhibitory factor, may be useful in this context: ELISA assays for myostatin and complementary measurement of the … [Read more]
The work of two researchers from the Institute awarded at the WMS
Two researchers from the institute were awarded prizes for their work at the WMS 2022 conference held in Halifax, Canada, and online from 11 to 15 October 2022. They received the Elsevier Subscription Prize: Harmen Reyngoult, co-team leader of NMR Laboratory – Spectroscopy Laboratory in the Neuromuscular Investigation Center, was awarded the prize for his Selected Flash poster: … [Read more]
Characterisation of PABPN1 aggregates in OPMD – Interview with Capucine Trollet
The results of an international study conducted by the Institute’s Capucine Trollet and Vincent Mouly team have just been published in Acta Neuropathologica. The article relates to the characterisation of PABPN1 aggregates performed on a unique series of 90 muscle biopsies from OPMD patients, collected from clinicians in France, Canada, the Netherlands and Israel, and on … [Read more]
Experts from the Institute at WMS 2022
The 27th World Muscle Society International Congress (WMS) will be held from October 11 to 15, 2022 in Halifax, Canada, as well as in a virtual version on the congress platform. International muscle experts will gather to discuss basic research, clinical trials and therapeutic advances in neuromuscular diseases. Researchers and clinicians from the Institute will be present, both … [Read more]
ERN EURO-NMD webinar, Oct. 13th : Robert Pangalila (The Netherlands)
Quality of life in Neuromuscular Disease Thursday October 13th, 2022 – 16:00-17:00 (Paris time) Robert Pangalila (Rijndam Rehabilitation Clinic and Erasmus University Medical Centre, The Netherlands) Please register here to attend the webinar Webinar organised by EURO-NMD in collaboration with ERN-RND and EAN.
A tool to evaluate cardiac risk in patients with mitochondrial disease – Interview with Karim Wahbi
Prof. Karim Wahbi, a cardiologist, has just published the results of an international study that he coordinated with his “Registries and databases” team at the Institute. The article relates to the prediction of cardiac consequences (complications) in adult patients with mitochondrial diseases*. What is the background to your conduct of this work? We have been … [Read more]
One word to describe the congress “Myology 2022”
Intriguing, friendly, fast-paced, cross-disciplinary… it’s not easy to sum up the 7th edition of the Myology Congress organized by the AFM-Telethon in a single word. Discover the answers of the researchers who took up the challenge! Myology 2022 is over! During 4 days, researchers, clinicians and experts in myology were able to exchange on the … [Read more]
ERN EURO-NMD webinar, Sept. 22nd : Prof. Costanza Lamperti (Italy)
Mitochondrial Genetics Thursday September 22nd, 2022 – 16:00-17:00 (Paris time) Prof. Costanza Lamperti (lstituto Neurologico C.Besta, Milan, Italy) Please register here to attend the webinar Webinar organised by EURO-NMD in collaboration with ERN-RND and EAN.
Myology 2022: opening session
On Monday, September 12, took place the opening session of the 7th edition of the international congress Myology 2022 was held with Laurence Tiennot-Herment, president of AFM-Telethon, and the co-presidents of the event, Elisabeth McNally, a specialist in cardiac muscle, and Shahragim Tajbakhsh, a specialist in muscle biology.
ACTA1 gene-related nemaline myopathies: an international study to clarify phenotypes
Pathological variants of the ACTA1 gene are responsible for half of the cases of nemaline myopathy (also known as rod myopathy). An international collaboration coordinated by the Institute of Myology of Paris collected data on ten new cases of this myopathy. The phenotype was globally very severe with an early onset and a high lethality. … [Read more]
